14 over 100 million proprietary Chinese medicine plasters exposed!

Medicine Net, June 15th, as China's traditional method of external administration, Chinese patent medicinal plasters have always been favored, and retail pharmacies are also its main sales channels
.
The latest data from Meinenet shows that the market growth rate of proprietary Chinese medicine plasters in physical pharmacies in cities in China will decline slightly in 2020, but the sales scale will still exceed 4.
5 billion yuan
.
From the product point of view, 14 products have sales of more than 100 million yuan.
Among them, Xiaotong Plaster is the only product with sales of more than 600 million yuan.
The ranking of Shexiang Zhuangguo cream has risen to The second place is close behind
.
In addition, the growth rate of the two major products is eye-catching, Tongluo Qutong Ointment has increased by more than 15% for three consecutive years; Musk Zhufeng Ointment has entered the echelon of 100 million yuan
.
It is worth mentioning that among the 14 products over 100 million yuan, 6 products including Xiaotong Plaster, Yunnan Baiyao Plaster, Ding Guier Navel Plaster, Tongluo Qutong Plaster, etc.
are exclusive products, involving Qizheng Tibetan Medicine, Yunnan Baiyao, Yabao 5 companies including Pharmaceutical and Lingrui Pharmaceutical
.

 

14 retail Chinese patent medicinal plasters exposed! Qizheng, Yabao, Lingrui.
.
.
6 exclusive products are eye-catching

 

Sales of proprietary Chinese medicine plasters in physical pharmacies in cities in China in recent years (unit: 100 million yuan)

Source: Mi Nei.
com, China's urban physical pharmacy terminal competition pattern

 

The latest data from Meinenet shows that in recent years, the sales of proprietary Chinese medicine plasters in physical pharmacies in cities in China have maintained growth.
In 2020, affected by the epidemic, the growth rate will decline slightly, but the sales scale still exceeds 4.
5 billion yuan
.
Chinese patent medicine plaster products with terminal sales exceeding 100 million in Chinese urban physical pharmacies in 2020

 

Source: Mi Nei.
com, China's urban physical pharmacy terminal competition pattern

 

From the product point of view, a total of 14 products have sales of more than 100 million yuan, with a total market share of more than 80%, and a high market concentration.
Among them, orthopedic analgesics have the largest number of drugs, accounting for half of the country
.
Xiaotong Plaster is the only product with a sales volume of over 600 million yuan.
It is the only product with a sales volume of over 600 million yuan.
Shexiang Zhuangguo has risen to the second place, following closely behind
.
Tongluo Qutong Ointment and Shexiang Zhuifeng Ointment grew at an impressive rate.
Tongluo Qutong Qutong Ointment increased by more than 15% for three consecutive years.
With strong growth rate, Shexiang Zhuifeng Ointment exceeded the 100 million yuan mark
.
In addition, among the 14 over 100 million products, Xiaotong Plaster, Yunnan Baiyao Plaster, Yunnan Baiyao Band-Aid Plaster, Ding Guier Navel Plaster, Tongluo Qutong Plaster, and Gutong Plaster are all exclusive products, involving Qizheng Tibetan Medicine, Yunnan Baiyao, 5 companies including Yabao Pharmaceutical and Lingrui Pharmaceutical
.

 

　　Over 600 million, Xiaotong Plaster has become a "explosive model"! Musk bone-strengthening cream followed closely

 

　　The market share of TOP3 market share of proprietary Chinese medicine plaster products in Chinese urban physical pharmacies in recent years

　　Source: Mi Nei.
com, China's urban physical pharmacy terminal competition pattern

 

　　Xiaotong Plaster is the exclusive product of Qizheng Tibetan Medicine
.
According to data from Meinenet, the market share of terminal pain relief plasters in physical pharmacies in Chinese cities has maintained steady growth in recent years, with sales exceeding 600 million yuan in 2020
.
Qizheng Tibetan Medicine stated that the company focuses on its own marketing model, combined with the refined investment management of some products , and covers a wide range of medical and retail terminals across the country
.
On the one hand, it is driven by academics to lead professionalism, and it will in-depth layout of county-level hospitals and primary medical markets, and accelerate the county expansion and channel sinking of medical terminals; on the other hand, focus on consumers, strengthen brand building and key city development, and actively promote O2O Business development, in-depth cooperation with Ele.
me, Meituan and other platforms to gain insights into consumers’ online drug purchase behaviors, cooperate with core chains to deploy O2O online stores, expand and strengthen retail, and achieve deepening of major hospitals, widening of grassroots, and retail Bigger business goals
.
In the first quarter of 2021, Qizheng Tibetan Medicine's performance continued to rise sharply, with revenue of 326 million yuan, a year-on-year increase of 113.
97%; net profit of 103 million yuan, a year-on-year increase of 112.
26%
.

 

　　Musk strong bone paste having anti-inflammatory analgesic effect, mainly for rheumatism, articular pain, back pain, neuralgia
.
According to data from Meinnet.
com, in recent years, the sales of Musk Zhuanggu Ointment in physical pharmacies in Chinese cities have exceeded 400 million yuan.
In 2020, its market share will surpass Yunnan Baiyao Ointment and rise to the second place
.
At present, there are more than 50 manufacturers of Musk Zhuanggu Ointment, involving nearly 60 approvals.
Among them, Guilin China Resources Tianhe Pharmaceutical has the largest market share, accounting for nearly 30%; Henan Lingrui Pharmaceutical and Xinhua Pharmaceutical Group ranks No.
The second and third place have a market share of more than 10%.
Among the three companies , Henan Lingrui Pharmaceutical has the fastest growth rate, exceeding 30%
.

 

　　The growth rate of Tongluo Qutong Ointment exceeded 15% for three consecutive years, and the Musk Zhufeng Ointment entered the 100 million yuan echelon

 

　　Sales of Tongluo Qutong Ointment at physical pharmacies in cities in China in recent years (unit: 100 million yuan)

　　Source: Mi Nei.
com, China's urban physical pharmacy terminal competition pattern

 

　　Tongluo Qutong Ointment is the exclusive product of Henan Lingrui Pharmaceutical
.
According to data from Menet.
com, the growth rate of Tongluo Qutong Ointment in physical pharmacies in cities in China has exceeded 15% in the past three years, and its sales in 2020 will exceed 200 million yuan
.
It is understood that Lingrui Pharmaceutical has established a multi-disciplinary and multi-level product pipeline covering orthopedics, pediatrics, cardio-cerebrovascular and other departments.
Among them, the 10 billion plaster project has been put into use.
Orthopedics products focus on Tongluo Qutong ointment, blood circulation and pain relief.
Exclusive varieties such as tincture have built a product matrix with clear levels, rich structures, and covering clinical and OTC terminals
.
Lingrui Pharmaceutical pointed out in its annual report that the company divides the three major business segments of OTC, primary medical care and clinical practice to carry out specialized sales work to achieve coverage of different terminals such as retail pharmacies and grade hospitals
.
The OTC line cooperates with large chain drugstores across the country , and the sales team provides comprehensive sales support and channel maintenance for commercial chains; primary medical and clinical lines continue to improve the company’s product market coverage and market coverage with professional and refined academic service promotion.
Share
.
In addition, the company is also accelerating the distribution of e-commerce sales channels through B2B and B2C models.
Currently, the company mainly deploys platforms such as Tmall and JD.
com
.

 

　　In recent years, the sales of Musk Zhu Feng ointment in physical drugstores in cities in China (unit: 100 million yuan)

　　Source: Mi Nei.
com, China's urban physical pharmacy terminal competition pattern

 

　　Musk Herd paste mainly used for rheumatic pain, joint pain, aching pain, neuralgia
.
According to data from Mi Nei.
com, in 2020, the sales of musk chasing ointment in physical pharmacies in cities in China will exceed 100 million yuan, and will be promoted to the billion yuan echelon with a strong growth rate of over 30%
.
At present, there are 5 manufacturers of this product.
Among them, Zhanjiang Jimin Pharmaceutical has the largest market share, Jiangsu Baiyi Pharmaceutical ranks second, and the total market share of the two is more than 80%
.

 

　　Conclusion

 

　　In February this year, the General Office of the State Council issued "Several Policy Measures on Accelerating the Development of Traditional Chinese Medicine with Characteristics" to provide policy support for the development of the Chinese medicine industry
.
Driven by factors such as the deepening of the population aging, the country's increasing investment in medical and health care, and the increasing awareness of public health care, the market demand for plasters will usher in growth in the future
.
Source: Mi Nei.
com database, announcement of listed companies

　　Medicine Net, June 15th, as China's traditional method of external administration, Chinese patent medicinal plasters have always been favored, and retail pharmacies are also its main sales channels
.
The latest data from Meinenet shows that the market growth rate of proprietary Chinese medicine plasters in physical pharmacies in cities in China will decline slightly in 2020, but the sales scale will still exceed 4.
5 billion yuan
.
From the product point of view, 14 products have sales of more than 100 million yuan.
Among them, Xiaotong Plaster is the only product with sales of more than 600 million yuan.
The ranking of Shexiang Zhuangguo cream has risen to The second place is close behind
.
In addition, the growth rate of the two major products is eye-catching, Tongluo Qutong Ointment has increased by more than 15% for three consecutive years; Musk Zhufeng Ointment has entered the echelon of 100 million yuan
.
It is worth mentioning that among the 14 products over 100 million yuan, 6 products including Xiaotong Plaster, Yunnan Baiyao Plaster, Ding Guier Navel Plaster, Tongluo Qutong Plaster, etc.
are exclusive products, involving Qizheng Tibetan Medicine, Yunnan Baiyao, Yabao 5 companies including Pharmaceutical and Lingrui Pharmaceutical
.

 

　　14 retail Chinese patent medicinal plasters exposed! Qizheng, Yabao, Lingrui.
.
.
6 exclusive products are eye-catching

 

　　Sales of proprietary Chinese medicine plasters in physical pharmacies in cities in China in recent years (unit: 100 million yuan)

　　Source: Mi Nei.
com, China's urban physical pharmacy terminal competition pattern

 

　　The latest data from Meinenet shows that in recent years, the sales of proprietary Chinese medicine plasters in physical pharmacies in cities in China have maintained growth.
In 2020, affected by the epidemic, the growth rate will decline slightly, but the sales scale still exceeds 4.
5 billion yuan
.
Chinese patent medicine plaster products with terminal sales exceeding 100 million in Chinese urban physical pharmacies in 2020

 

　　

　　Source: Mi Nei.
com, China's urban physical pharmacy terminal competition pattern

 

　　From the product point of view, a total of 14 products have sales of more than 100 million yuan, with a total market share of more than 80%, and a high market concentration.
Among them, orthopedic analgesics have the largest number of drugs, accounting for half of the country
.
Xiaotong Plaster is the only product with a sales volume of over 600 million yuan.
It is the only product with a sales volume of over 600 million yuan.
Shexiang Zhuangguo has risen to the second place, following closely behind
.
Tongluo Qutong Ointment and Shexiang Zhuifeng Ointment grew at an impressive rate.
Tongluo Qutong Qutong Ointment increased by more than 15% for three consecutive years.
With strong growth rate, Shexiang Zhuifeng Ointment exceeded the 100 million yuan mark
.
In addition, among the 14 over 100 million products, Xiaotong Plaster, Yunnan Baiyao Plaster, Yunnan Baiyao Band-Aid Plaster, Ding Guier Navel Plaster, Tongluo Qutong Plaster, and Gutong Plaster are all exclusive products, involving Qizheng Tibetan Medicine, Yunnan Baiyao, 5 companies including Yabao Pharmaceutical and Lingrui Pharmaceutical
.

 

　　Over 600 million, Xiaotong Plaster has become a "explosive model"! Musk bone-strengthening cream followed closely

 

　　The market share of TOP3 market share of proprietary Chinese medicine plaster products in Chinese urban physical pharmacies in recent years

　　Source: Mi Nei.
com, China's urban physical pharmacy terminal competition pattern

 

　　Xiaotong Plaster is the exclusive product of Qizheng Tibetan Medicine
.
According to data from Meinenet, the market share of terminal pain relief plasters in physical pharmacies in Chinese cities has maintained steady growth in recent years, with sales exceeding 600 million yuan in 2020
.
Qizheng Tibetan Medicine stated that the company focuses on its own marketing model, combined with the refined investment management of some products , and covers a wide range of medical and retail terminals across the country
.
On the one hand, it is driven by academics to lead professionalism, and it will in-depth layout of county-level hospitals and primary medical markets, and accelerate the county expansion and channel sinking of medical terminals; on the other hand, focus on consumers, strengthen brand building and key city development, and actively promote O2O Business development, in-depth cooperation with Ele.
me, Meituan and other platforms to gain insights into consumers’ online drug purchase behaviors, cooperate with core chains to deploy O2O online stores, expand and strengthen retail, and achieve deepening of major hospitals, widening of grassroots, and retail Bigger business goals
.
In the first quarter of 2021, Qizheng Tibetan Medicine's performance continued to rise sharply, with revenue of 326 million yuan, a year-on-year increase of 113.
97%; net profit of 103 million yuan, a year-on-year increase of 112.
26%
.

 

　　Musk strong bone paste having anti-inflammatory analgesic effect, mainly for rheumatism, articular pain, back pain, neuralgia
.
According to data from Meinnet.
com, in recent years, the sales of Musk Zhuanggu Ointment in physical pharmacies in Chinese cities have exceeded 400 million yuan.
In 2020, its market share will surpass Yunnan Baiyao Ointment and rise to the second place
.
At present, there are more than 50 manufacturers of Musk Zhuanggu Ointment, involving nearly 60 approvals.
Among them, Guilin China Resources Tianhe Pharmaceutical has the largest market share, accounting for nearly 30%; Henan Lingrui Pharmaceutical and Xinhua Pharmaceutical Group ranks No.
The second and third place have a market share of more than 10%.
Among the three companies , Henan Lingrui Pharmaceutical has the fastest growth rate, exceeding 30%
.

 

　　The growth rate of Tongluo Qutong Ointment exceeded 15% for three consecutive years, and the Musk Zhufeng Ointment entered the 100 million yuan echelon

 

　　Sales of Tongluo Qutong Ointment at physical pharmacies in cities in China in recent years (unit: 100 million yuan)

　　Source: Mi Nei.
com, China's urban physical pharmacy terminal competition pattern

 

　　Tongluo Qutong Ointment is the exclusive product of Henan Lingrui Pharmaceutical
.
According to data from Menet.
com, the growth rate of Tongluo Qutong Ointment in physical pharmacies in cities in China has exceeded 15% in the past three years, and its sales in 2020 will exceed 200 million yuan
.
It is understood that Lingrui Pharmaceutical has established a multi-disciplinary and multi-level product pipeline covering orthopedics, pediatrics, cardio-cerebrovascular and other departments.
Among them, the 10 billion plaster project has been put into use.
Orthopedics products focus on Tongluo Qutong ointment, blood circulation and pain relief.
Exclusive varieties such as tincture have built a product matrix with clear levels, rich structures, and covering clinical and OTC terminals
.
Lingrui Pharmaceutical pointed out in its annual report that the company divides the three major business segments of OTC, primary medical care and clinical practice to carry out specialized sales work to achieve coverage of different terminals such as retail pharmacies and grade hospitals
.
The OTC line cooperates with large chain drugstores across the country , and the sales team provides comprehensive sales support and channel maintenance for commercial chains; primary medical and clinical lines continue to improve the company’s product market coverage and market coverage with professional and refined academic service promotion.
Share
.
In addition, the company is also accelerating the distribution of e-commerce sales channels through B2B and B2C models.
Currently, the company mainly deploys platforms such as Tmall and JD.
com
.

 

　　In recent years, the sales of Musk Zhu Feng ointment in physical drugstores in cities in China (unit: 100 million yuan)

　　Source: Mi Nei.
com, China's urban physical pharmacy terminal competition pattern

 

　　Musk Herd paste mainly used for rheumatic pain, joint pain, aching pain, neuralgia
.
According to data from Mi Nei.
com, in 2020, the sales of musk chasing ointment in physical pharmacies in cities in China will exceed 100 million yuan, and will be promoted to the billion yuan echelon with a strong growth rate of over 30%
.
At present, there are 5 manufacturers of this product.
Among them, Zhanjiang Jimin Pharmaceutical has the largest market share, Jiangsu Baiyi Pharmaceutical ranks second, and the total market share of the two is more than 80%
.

 

　　Conclusion

 

　　In February this year, the General Office of the State Council issued "Several Policy Measures on Accelerating the Development of Traditional Chinese Medicine with Characteristics" to provide policy support for the development of the Chinese medicine industry
.
Driven by factors such as the deepening of the population aging, the country's increasing investment in medical and health care, and the increasing awareness of public health care, the market demand for plasters will usher in growth in the future
.
Source: Mi Nei.
com database, announcement of listed companies